Semaglutide for weight management (Wegovy) is FDA-approved only for adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia
We found that semaglutide and, to a lesser extent, liraglutide were associated with significantly lower risk of worsening mental illness in people using antidiabetic medications, compared with time periods when GLP-1 receptor agonists were not used, the study said
doi: 10.3389/fendo.2022.1043789 7
It is not the time to explore or salvage relationships
In research settings, KLOW peptide is used in preclinical models of joint stress, tendon and ligament overload, wound repair, and multi-pathway tissue recovery
Recent advances in proteomic studies of adipose tissues and adipocytes